+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 70 Pages
  • August 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5659122
The Asia Pacific Narcolepsy Therapeutics Market is expected to witness market growth of 11.4% CAGR during the forecast period (2022-2028).

Narcoleptics have a strong want to sleep and are low on energy. Cataplexy is an abrupt loss of muscle tone and weakness that might last for a few seconds or several minutes. It frequently happens when under the stress of weariness; it is brought on by feelings like fear, laughing, or surprise. Temporarily being unable to move any portion of the body is the hallmark of sleep paralysis. Fear sets it off, but it has no negative effects. Narcoleptics may also hallucinate, which are characterized by vivid, frequently terrifying dreams.

Any mental disorder, a deficiency in the brain chemical hypocretin, hereditary conditions, infections, trauma, hormonal changes, stress, immune-system failure, etc. can all contribute to narcolepsy. A hereditary predisposition exists in around 10% of people who develop narcolepsy with cataplexy. Men and women of any age can develop narcolepsy, which can start in the early 20s and last the rest of their lives. In the United States, it is estimated that one person in every 2000 individuals has narcolepsy, and those who have it live regular lives.

It was conducted in the family medicine outpatient department at St. Philomena's Hospital, Bengaluru, as part of a cross-sectional study. Written consent was obtained from all adult patients visiting the outpatient department between September 1st and October 30th, 2015. They used the Athens Insomnia Scale to diagnose insomnia and gathered data on co-morbidities in medicine. To determine the prevalence of insomnia and its associated co-morbidities, examined the data.

The China market dominated the Asia Pacific Narcolepsy Therapeutics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $432.8 million by 2028.The Japan market is estimated to grow a CAGR of 10.7% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 12.1% during (2022 - 2028).

Based on Type, the market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy and Secondary Narcolepsy. Based on Product, the market is segmented into Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type
  • Narcolepsy with Cataplexy
  • Narcolepsy Without Cataplexy
  • Secondary Narcolepsy
By Product
  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Narcolepsy Therapeutics Market, by Type
1.4.2 Asia Pacific Narcolepsy Therapeutics Market, by Product
1.4.3 Asia Pacific Narcolepsy Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Narcolepsy Therapeutics Market by Type
3.1 Asia Pacific Narcolepsy with Cataplexy Market by Country
3.2 Asia Pacific Narcolepsy Without Cataplexy Market by Country
3.3 Asia Pacific Secondary Narcolepsy Market by Country
Chapter 4. Asia Pacific Narcolepsy Therapeutics Market by Product
4.1 Asia Pacific Sodium Oxybate Market by Country
4.2 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country
4.3 Asia Pacific Central Nervous System Stimulants Market by Country
4.4 Asia Pacific Tricyclic Antidepressants Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Narcolepsy Therapeutics Market by Country
5.1 China Narcolepsy Therapeutics Market
5.1.1 China Narcolepsy Therapeutics Market by Type
5.1.2 China Narcolepsy Therapeutics Market by Product
5.2 Japan Narcolepsy Therapeutics Market
5.2.1 Japan Narcolepsy Therapeutics Market by Type
5.2.2 Japan Narcolepsy Therapeutics Market by Product
5.3 India Narcolepsy Therapeutics Market
5.3.1 India Narcolepsy Therapeutics Market by Type
5.3.2 India Narcolepsy Therapeutics Market by Product
5.4 South Korea Narcolepsy Therapeutics Market
5.4.1 South Korea Narcolepsy Therapeutics Market by Type
5.4.2 South Korea Narcolepsy Therapeutics Market by Product
5.5 Singapore Narcolepsy Therapeutics Market
5.5.1 Singapore Narcolepsy Therapeutics Market by Type
5.5.2 Singapore Narcolepsy Therapeutics Market by Product
5.6 Malaysia Narcolepsy Therapeutics Market
5.6.1 Malaysia Narcolepsy Therapeutics Market by Type
5.6.2 Malaysia Narcolepsy Therapeutics Market by Product
5.7 Rest of Asia Pacific Narcolepsy Therapeutics Market
5.7.1 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type
5.7.2 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product
Chapter 6. Company Profiles
6.1 Jazz Pharmaceuticals plc
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Approvals and Trials:
6.2 Shionogi & Co., Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Research & Development Expenses
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional & Segmental Analysis
6.4.4 Research & Development Expense
6.5 Bioprojet
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 Takeda Pharmaceutical Company Limited
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Ligand Pharmaceuticals, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Graymark Healthcare, Inc.
6.8.1 Company Overview

Companies Mentioned

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Methodology

Loading
LOADING...